1. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
    Shaheen Mahira et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  2. Letter to the editor: ‘current advances in development of new docetaxel formulations’
    Mujtaba A. Khan et al, 2019, Expert Opinion on Drug Delivery CrossRef
  3. A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer
    Aseem Samar et al, 2020, Prostate Cancer CrossRef
  4. Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective study
    Sundaram Subramanian et al, 2021, Molecular and Clinical Oncology CrossRef
  5. Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study
    Prasad Narayanan et al, 2019, Sarcoma CrossRef

  6. Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use


    Madhusmita Dhupal et al, 2020, International Journal of Nanomedicine CrossRef

  7. Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study


    Sundaram Subramanian et al, 2020, Breast Cancer: Targets and Therapy CrossRef
  8. Efficacy and safety of DoceAqualip in a patient with locally advanced cervical cancer: A case report
    Rammohan Prasanna et al, 2017, Molecular and Clinical Oncology CrossRef
  9. The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
    Peter van Hoogevest et al, 2021, European Journal of Lipid Science and Technology CrossRef
  10. Letter to the Editor: "Docetaxel and its nanoformulations: how delivery strategies could impact the therapeutic outcome?”
    Mujtaba A Khan et al, 2021, Therapeutic Delivery CrossRef
  11. Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case series
    Srikant Tiwari et al, 2021, Journal of Oncology Pharmacy Practice CrossRef
  12. A fast strategy for profiling and identifying pharmaceutic excipient polysorbates by ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry
    Zhe Wang et al, 2020, Journal of Chromatography A CrossRef
  13. A nanoscale, biocompatible and amphiphilic prodrug of cabazitaxel with improved anticancer efficacy against 3D spheroids of prostate cancer cells
    Ashok Kumar Jangid et al, 2020, Materials Advances CrossRef
  14. Advanced nanomaterial for point-of-care chemotherapy
    Soumya S. Panda et al, 2022, Advanced Nanomaterials for Point of Care Diagnosis and Therapy CrossRef